A Study of the Effect of Itraconazole and Phenytoin on MK-1084 in Healthy Adults (MK-1084-008)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

July 30, 2024

Study Completion Date

July 30, 2024

Conditions

Healthy

Interventions

DRUG

MK-1084

Oral Tablet

DRUG

Itraconazole

Oral solution

DRUG

Phenytoin

Oral capsule (extended)

Trial Locations (1)

Celerion (Site 0001), Lincoln

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT06719557 - A Study of the Effect of Itraconazole and Phenytoin on MK-1084 in Healthy Adults (MK-1084-008) | Biotech Hunter | Biotech Hunter